Invasive Ductal Carcinoma in a 46,XY Partial Androgen Insensitivity Syndrome Patient on Hormone Therapy

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Background: The hormonal management of patients with androgen insensitivity can be challenging. Case: An illustrative case is presented of a newborn with ambiguous genitalia who was raised female. She was diagnosed as 46,XY Disorder of Sexual Development with partial androgen insensitivity. To induce puberty, conjugated equine estrogens were administered beginning at age 12. At age 13, she instead began taking combined oral contraceptives for maternal concerns about height and continued taking them for social reasons. Invasive ductal carcinoma was diagnosed at age 27, and the patient was treated with chemotherapy, radiation therapy, bilateral mastectomies, and endocrine therapy. Summary and Conclusion: The current literature is reviewed, and hormonal management and other risks for breast cancer are discussed.

Original languageEnglish
Pages (from-to)e95-e97
JournalJournal of Pediatric and Adolescent Gynecology
Volume28
Issue number4
DOIs
StatePublished - Aug 1 2015

Keywords

  • 46,XY disorders of sexual development
  • Androgen insensitivity syndrome
  • Breast Neoplasms

Fingerprint Dive into the research topics of 'Invasive Ductal Carcinoma in a 46,XY Partial Androgen Insensitivity Syndrome Patient on Hormone Therapy'. Together they form a unique fingerprint.

  • Cite this